These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15671089)

  • 21. Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness.
    Murray RD; Wieringa G; Lawrance JA; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):508-15. PubMed ID: 20039899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular risk of GH-deficient adolescents.
    Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
    Lanes R; Soros A; Flores K; Gunczler P; Carrillo E; Bandel J
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3978-82. PubMed ID: 15870123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency.
    Araujo VP; Aguiar-Oliveira MH; Oliveira JL; Rocha HM; Oliveira CR; Rodrigues TM; Nunes MA; Britto IM; Ximenes R; Barreto-Filho JA; Meneguz-Moreno RA; Pereira RM; Valença EH; Oliveira-Neto LA; Vicente TA; Blackford A; Salvatori R
    Eur J Endocrinol; 2012 Jun; 166(6):977-82. PubMed ID: 22416078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
    Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood obesity-related cardiovascular risk factors and carotid intima-media thickness.
    Simşek E; Balta H; Balta Z; Dallar Y
    Turk J Pediatr; 2010; 52(6):602-11. PubMed ID: 21428192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-I concentrations are positively associated with carotid artery atherosclerosis in women.
    Hietaniemi M; Pöykkö SM; Ukkola O; Päivänsalo M; Antero Kesäniemi Y
    Ann Med; 2005; 37(5):373-82. PubMed ID: 16179273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
    Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.
    Colao A; Spiezia S; Di Somma C; Pivonello R; Marzullo P; Rota F; Musella T; Auriemma RS; De Martino MC; Lombardi G
    J Endocrinol Invest; 2005 May; 28(5):440-8. PubMed ID: 16075928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.